Use of botulinum neurotoxin to treat substance addictions
AssigneeToxcure, Inc.
InventorChristopher Shaari
Life of this patent
Estimating the term…
Loading patent…
AssigneeToxcure, Inc.
InventorChristopher Shaari
Estimating the term…
The present invention provides methods for treating a substance addiction- related behavior in a patient with a substance addiction, comprising the step of locally administering a therapeutically effective amount of a botulinum neurotoxin to a location on the patient's body or in the vicinity of the area which comes into contact with a smoking tool or addictive substance, thereby altering, reducing or eliminating sensations associated with behaviors associated with substance addiction. Botulinum neurotoxin may be administered to a dermal, subdermal, mucosal or submucosal location or to a muscle area or in the vicinity of the location to which a smoking tool or addictive substance contacts.
A method of treating substance addiction-related behaviors in a patient, comprising the step of locally administering a therapeutically effective dose of a botulinum neurotoxin to a location on the patient's body or in the vicinity of the location which comes into contact with a smoking tool or addictive substance.
Dependencies are inferred from the claim text.